Sight Sciences SGHT
NASDAQ SGHT
$8.15 +0.05 (+0.56%)
As of: Sep 9, 2026 · 12:08 PM EDT

Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026)

Sight Sciences (SGHT) posted Net Income towards Common Stockholders of -$4.4 million for Q2 2026, up 65.75% on a QoQ basis from -$13.0 million in Q1 2026, and up 62.77% year-over-year from -$2.7 million in Q2 2025.

Analysis

Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Sight Sciences has reported Net Income towards Common Stockholders for 7 years, with the latest figure at -$4.4 million in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 62.77% year-over-year to -$4.4 million in Q2 2026; TTM through Jun 2026 was -$21.7 million, a 55.76% increase from a year earlier, with the FY2025 full-year figure at -$30.3 million, up 41.08% from the prior year.
  • Net Income towards Common Stockholders was -$4.4 million for Q2 2026 at Sight Sciences, up from -$13.0 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $3.9 million in Q4 2025, with the low at -$23.8 million in Q2 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$13.4 million, with a median of -$13.0 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders sank 90.06% in 2022, then jumped 133.05% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at -$16.9 million in 2022, then jumped by 36.77% to -$10.7 million in 2023, then retreated by 10.8% to -$11.8 million in 2024, then soared by 133.05% to $3.9 million in 2025, then slumped by 213.56% to -$4.4 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$4.4 million (Q2 2026), -$13.0 million (Q1 2026), and $3.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 184.42 Bn 178.82 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 124.16 Bn 118.94 Bn 1.96 Bn 823.20 Mn
3 Medtronic 118.41 Bn 109.59 Bn 6.34 Bn 1.48 Bn
4 Stryker 104.45 Bn 100.98 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.47 Bn 65.93 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.71 Bn 45.46 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.95 Bn 32.50 Bn 1.68 Bn -
8 Dexcom 32.24 Bn 30.29 Bn 830.00 Mn 249.10 Mn
9 Steris 21.17 Bn 20.68 Bn 684.20 Mn 201.00 Mn
10 Sight Sciences 443.68 Mn 363.92 Mn 21.37 Mn -4.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.45 Mn
Mar 31, 2026 -12.98 Mn
Dec 31, 2025 3.92 Mn
Sep 30, 2025 -8.17 Mn
Jun 30, 2025 -11.94 Mn
Mar 31, 2025 -14.15 Mn
Dec 31, 2024 -11.85 Mn
Sep 30, 2024 -11.07 Mn
Jun 30, 2024 -12.33 Mn
Mar 31, 2024 -16.27 Mn
Dec 31, 2023 -10.69 Mn
Sep 30, 2023 -13.04 Mn
Jun 30, 2023 -14.75 Mn
Mar 31, 2023 -17.07 Mn
Dec 31, 2022 -16.91 Mn
Sep 30, 2022 -22.23 Mn
Jun 30, 2022 -23.84 Mn
Mar 31, 2022 -23.26 Mn
Dec 31, 2021 -15.94 Mn
Sep 30, 2021 -17.17 Mn